Rizatriptan Drug Profile

What is Rizatriptan?

Rizatriptan is a prescription medication belonging to a class of drugs called triptans, specifically designed to treat migraine headaches. It works by targeting specific receptors in the brain and blood vessels to provide rapid relief from migraine symptoms. Rizatriptan is typically used for acute treatment of migraine attacks rather than prevention.

Uses

Rizatriptan is primarily prescribed for the following conditions:

• Acute migraine treatment: The primary use for treating moderate to severe migraine headaches in adults
• Migraine with aura: Effective for migraines preceded by visual or sensory disturbances
• Migraine without aura: Treatment of common migraines without warning symptoms
• Migraine-associated symptoms: Helps relieve nausea, vomiting, and light sensitivity that accompany migraines
• Cluster headache treatment: Sometimes used off-label for certain types of severe headaches, though not FDA-approved for this use

How it works

Rizatriptan works by binding to serotonin receptors, specifically 5-HT1B and 5-HT1D receptors, in blood vessels and nerve pathways in the brain. This action causes the dilated blood vessels around the brain to constrict, reducing inflammation and blocking pain signals. The medication also inhibits the release of certain chemicals that contribute to migraine pain and associated symptoms.

Side effects

Common side effects include:

Submit Your Paper

• Dizziness and drowsiness
• Fatigue and weakness
• Nausea
• Dry mouth
• Chest tightness or pressure
• Tingling sensations in hands or feet
• Warm or hot sensations
• Pain or pressure in the neck or throat

Serious side effects that require immediate medical attention:

• Severe chest pain or heart attack symptoms
• Signs of stroke, including sudden numbness or weakness
• Severe allergic reactions with difficulty breathing or swelling
• Medication overuse headaches from frequent use
• Severe high blood pressure episodes

Warnings and precautions

• Cardiovascular conditions: Should not be used by patients with heart disease, coronary artery disease, or uncontrolled high blood pressure due to risk of heart attack or stroke
• Pregnancy and breastfeeding: Limited safety data available; should only be used if potential benefits outweigh risks and under medical supervision
• Liver impairment: Dosage adjustments may be necessary for patients with liver problems, as the medication is processed by the liver
• Age restrictions: Not recommended for patients over 65 years old due to increased risk of cardiovascular side effects
• Frequency limits: Should not be used more than 10 days per month to avoid medication overuse headaches

Interactions

• MAO inhibitors: Can significantly increase rizatriptan levels, requiring dose reduction and careful monitoring
• Other triptans: Should not be taken within 24 hours of other triptan medications due to additive effects
• Ergotamine medications: Concurrent use can cause severe vasoconstriction and should be avoided
• Propranolol: This beta-blocker increases rizatriptan blood levels, requiring dose adjustment
• SSRIs and SNRIs: Antidepressants may increase risk of serotonin syndrome when combined with rizatriptan
• St. John’s Wort: This herbal supplement may reduce rizatriptan effectiveness
• Sumatriptan: Should not be used together due to similar mechanisms and increased side effect risk
• Methysergide: Can cause additive vasoconstriction effects

Check interactions with the GMJ Interaction Checker

Dosage

The typical adult dosage of rizatriptan is 5 to 10 mg taken orally at the onset of migraine symptoms. If the headache returns, a second dose may be taken after at least 2 hours, but no more than 30 mg should be taken in a 24-hour period. Patients taking propranolol should use a maximum dose of 5 mg due to drug interactions. The medication is available in both regular tablets and orally disintegrating tablets. Dosage should always be determined by a healthcare provider based on individual patient factors, medical history, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).